chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got the vaccine about 3 years ago, soon had shingles/ Suspected vaccination failure; Soon had shingles; Broke out with another skin condition; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and skin disorder. The patient was treated with steroids nos (Steroids), antibiotics nos, medication unknown (Pill (Medication Unknown)) and dermatologicals nos (Salve (Nos)). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and skin disorder were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and skin disorder to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-SEP-2022 Reporter's comment: This case was reported by the patient via interactive digital media. The patient got the vaccine about 3 years prior to the reporting. Soon he had shingles. The patient had received steroids and antibiotics later, he broke out with another skin condition with one of those long names. The patient had more prescribed with steroids, antibiotics, trips by a dermatologist. He was still taking pills that cancer patients took and used in a special salve to control the outbreak. The patient had no trust on vaccine. Additional supportive information: The follow-up would not possible, as no contact details were available.
I was diagnosed by Dr. on 5/27/2021 as having shingles.  He did not communicate any connection to the virus.  After researching online, I saw where there was some evidence of a connection, and to report it here.  I was prescribed ValACYclovir which I began taking on 5/27/2021.
Had bright red menstrual bleeding start the day after the vaccine and it continued for 6 days.
Patient notified pain at the injection site and whole arm and flu-like symptoms. She informs she had a fever but temp unknown. Patient receives cephalexin 250 QID with cellulitis diagnosis 8/2/17.
This spontaneous report was received from a registered nurse regarding an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with GARDASIL 9 (lot #, expiration date, dose and route were not reported) for prophylaxis that were improperly stored. The storage temperature was 9C and time frame was 1 hour. No adverse effects was reported. There was no previous excursion or data logger. This is one of the reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1707USA006444: US-009507513-1707USA008758: US-009507513-1707USA008759.
part of her face fell, right side of face; injection site was swollen; injection site was bruise; Initial information received on 31-Oct-2019 regarding an unsolicited valid serious case received from a consumer.  This case involves female patient (age not reported) who experienced injection site was swollen (vaccination site swelling), injection site was bruise (vaccination site bruising) and part of her face fell, right side of face (facial paralysis), while she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in the left arm.  On an unknown date, the patient developed a serious part of her face fell, right side of face (facial paralysis) (unknown latency) following the administration of INFLUENZA VACCINE. This was case serious due to important medical event- Facial paralysis.  On an unknown date, the patient developed a non-serious injection site was swollen (vaccination site swelling) and injection site was bruise (vaccination site bruising) (unknown latency) following the administration of INFLUENZA VACCINE.  Other relevant tests not reported.   Final diagnosis was vaccination site swelling, vaccination site bruising and facial paralysis.  It was not reported if the patient received a corrective treatment.  The outcome was unknown for vaccination site swelling, vaccination site bruising and facial paralysis.; Sender's Comments: This case concerns a female patient (age not reported) who experienced vaccination site swelling, vaccination site bruising and facial paralysis after vaccination with INFLUENZA VACCINE(unk mfr). The time to onset was unknown. However, patient's medical history, medical condition at time of vaccination and lab test ruling out alternate etiologies were not reported. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
h/a 5mins p/vax progressed to severe h/a also w/in 5mins bad taste in mouth, next day n/v & severe diarrhea, resolved in 36-48hrs;
EXTREME SORENESS ON 6/25/2017,TOOK A TYLONAL IN ORDER TO SLEEP. I DRESSED IN THE AM BUT DID NOT NOTICE THE BLOTCHY RASH AROUND INJECTION SITE UNTIL 11PM AT WHICH TIME I SAW STREAKS OF RED SWOLLEN AREAS ACROSS MY UPPER LEFT ARM AND ARM PIT GOING ACROSS TO MY CHEST. THERE HAD BEEN LIGHT ITCHING BUT NOTHING THAT MADE ME CHECK MY SKIN BEFORE I UNDRESSED. I HAVE NEVER HAD A REACTION TO ANY VACCINE BEFORE.
he was experiencing chills; runny nose; his temp, it was about 100.3 degrees Fahrenheit; This is a spontaneous report from contactable consumer reported for a patient (Reporters husband) via a   Sponsored Program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Not Provided), via an unspecified route of administration  on 13Feb2021 as a single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported.  On 19Feb2021, The patient experienced chills, , runny nose and his temp, it was about 100.3 degrees Fahrenheit.  The caller inquired  if her husband's symptoms, are due to the vaccine side effects or should he test for COVID? The clinical course is as follows Her husband got his first dose last 13Feb2021. Last night 19Feb2021, he was experiencing chills, runny nose and upon checking his temp, it was about 100.3 degrees Fahrenheit. The patient underwent lab tests and procedures which included pyrexia: 100.3 Fahrenheit on 19Feb2021. The he clinical outcome of the events chills, runny nose and fever were unknown.    Information on the lot/batch number has been requested
Shortness of breath and itchy rash on neck approximately 3 days after vaccine administered. The vaccine was not given at this facility, but patient came to this office for evaluation
Person was given 0.3cc dose of Janssen Booster dose instead of standard 0.5 cc. Regulatory Authority notified and Manufacturer (Janssen) notified and all persons reported to Janssen Manufacturer for their Pharmacy department, recommendations from the Manufacturer and with agreement from RA are to notify all of the recipients that received an incorrect dose and submit a VAERS report for each.
Systemic: Dizziness / Lightheadness-Mild, Additional Details: felt light headed / dizzy after about 5 minutes of receiving vaccine. started to feel better after having his head down toward lap. monitored patient for 20 minutes before allowing him to go outside of observation area.
A subject, age and sex not reported, received  the 5th dose of Anthrax vaccine (Lot FAV047) on an unspecified date and experienced the event of muscle twitching for one week, in the arm opposite to the one where injection was given. Date of onset of event, date of vaccination, outcome, and treatment are unk. No further information in known. Follow up attempts were unsuccessful.
Injection site pain, muscle pain, could not raise arm up high,  chills, whole body ached, joints hurt, weak, mild consistent headache, nausea, skin sensitivity, feeling like a bad case of the flu for 30 hours. Getting better by Sunday evening. Still not 100% as of Tuesday. Slight headache comes and goes like a sinus infection would feel like.
Information has been received from a physician concerning a 76 year old female patient with food allergy to mango and no other medical history who was vaccinated with a 0.5 ml IM dose of PNEUMOVAX 23 greater than 5 years ago (lot # 658555/0964U). About 24 hours after receiving PNEUMOVAX 23 the patient experienced cellulitis of the arm at the injection site characterized by a very swollen, red and tender arm. No lab diagnostics studies were performed. At the time of this report, the adverse event was ongoing. The patient sought medical attention via office visit. Cellulitis of the arm at the injection site was considered to be disabling. This is one of several reports from the same source. Additional information has been requested.
Patient developed allergic reaction to NSAIDs (e.g. Advil) in the week after the 1st booster shot (1st two doses Moderna, booster Pfizer). Started with skin swelling and continued with trouble breathing. Reactions continued to worse with additional use of NSAIDs until identified to be the trigger.
I took a home test May 25 it came back positive I called my PCP and they prescribed Paxlovid. I took it I had bad cold symptom; runny nose, sore throat, fever 102, coughing, not feeling well in general. I think I contracted in for a trip and I had trip travel through 4 different flights. I isolated for 5 days and wore a mask. On May 4th I went to a play, and I felt sick again and I was positive again. Called the PCP again they told me to just isolate for 5 days and wear a mask. They told me that there wasn?t much they could do. I tested negative after 5 days the first time before going to the play.  Unsure of LOT number because it was written by hand.
Fever 102.5 8 1/2cm x 9 1/2cm (L) upper arm induration & pink red color. Pain & decreased mobility secondary to pain. Ibuprofen & BENADRYL given. Also has tonsils with exudate but not red. Rapid strep test (-). Back-up sent to lab.
A week after 1st vaccine noticed L. supraclavicular lymph node. Day after my second vaccine, developed 2 more L. anterior chain cervical lymph nodes. After testing below, lymph nodes have gradually decreased in size. 16 weeks pregnant at time of 1st vaccine. EDD 6/26/21.  2/26/21 Fungal culture from lymph node resection negative
This spontaneous report as received from a pharmacist refers to a patient of unknown age. On 18-SEP-2014 the patient was vaccinated with an expired dose of M-M-R II (dose not reported, lot # H015833, expiration date 24-AUG-2014, subcutaneously. No known adverse effects. Additional information has been requested.
3RD DOSE OF MODERNA COVID VACCINE GIVEN 11/17/21, LOT #065F21A; pt in Health and Rehab facility; pt had a positive COVID test in facility on 7/15/22; pt passed away in the facility 7 days later
33 yo M in good health with acute stroke. Moderna Booster on 1/18/22. Acute stroke on 2/8/2022. Acute ischemic infarct, right cerebellum. Right upper extremity incoordination and speech difficulties, resolved. Headache, resolved. Status post COVID.  Booster with Moderna on 01/18/2022. Family history of thrombotic events with a brother with stroke and heart disease at the age of 35. Possible NSAID ALLERGY which apparently cause difficulty with breathing and swallowing. During course of patients hospital stay his slurred speech and right hand weakness improved readily.  MRI showing right nonhemorrhagic cerebellar stroke.  TEE performed by cardiology.  Bubble study was negative which rules out PFO.  TEE also negative for any other abnormal findings.  Neurology recommending that patient continue on dual antiplatelet therapy with aspirin and Plavix with directions to discontinue Plavix after 21 days, continuing aspirin going forward.  Neurology also wants patient to continue on a statin medication, patient started on atorvastatin 40.  Neurology requesting that patient receive a Holter monitor which cardiology has scheduled him to receive at their clinic at 1 PM this afternoon.  Patient to be discharged now with follow-up for this appointment.   Of note: Patient has a brother who also had stroke symptoms and received 3 stents indicating there might be a genetic component underlying patient's recent stroke.  The patient received a COVID vaccine 1 month ago cannot rule out post vaccination side effect   2/11 Discharge :  Stroke due to occlusion of right cerebellar artery  #Slurred speech- improved  #L hand weakness- improved ?Patient with brother who also had stroke and arterial disease which required stenting indicating possible genetic component ?Patient status post Covid vaccine 1 month ago, ischemic strokes are unknown albeit rare complication of this vaccine ?Patient's stroke symptoms have largely resolved however concern regarding preventing future strokes remains ?Neurology consulted for further work-up and assistance ?Neurology planning on coagulation panel, bubble study, and TEE ?Continue to monitor on telemetry to assess for possible underlying paroxysmal A. fib ?Neurology is also recommending DAPT for 21 days at which point patient can stop taking Plavix and remain on aspirin only ?Neurology also recommending continued statin therapy ?TEE this AM negative and bubble study not showing PFO  -Neuro recommending holter monitor x72 hours  -Patient with visit planned for today at clinic for holter  -ok for DC
Information has been received from a physician concerning a 9 week old male patient with no drug allergies who on 22-OCT-2009 was vaccinated orally with a first dose of ROTATEQ (lot# not reported). On 11-NOV-2009 the patient was diagnosed with rotavirus. The patient was hospitalized but no demographic was provided. At the time of this report, the patient had not recovered. Rotavirus was considered to be immediately disabling and life-threatening. Additional information has been requested.
Onset chills, headache with vomiting approximately 5 hours after vaccine administration. Mild headache persisted late pm 11/2/11. Chills and vomiting resolved 6am 11/2/11. 11/03/11 am feels fine now. Individual advised to discuss sxs with PMP prior to next years flu season.
TIRED FOR A DAY; This spontaneous report received from a patient via a company representative (via social media) concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced tired for a day. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tired for a day. This report was non-serious.
The patient began experiencing chest discomfort since receiving her second Pfizer COVID vaccine on Monday afternoon (9/14).  The chest discomfort started Tuesday (9/15) afternoon and persisted through until this morning.  She describes it as a central substernal aching or heaviness, not associated with any palpitations.  It is non-radiating and is not associated with nausea, vomiting, diaphoresis, syncope or breathing problems.  She has had no fever, chills, cough, or other infectious symptomatology.
No adverse reaction was reported; missed their third dose of GARDASIL 9 that was supposed to occur six months after the initial dose; This spontaneous report was received from a consumer referring to her currently 18-year-old son, a male patient. His concurrent conditions, medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date in October 2018, the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, dose, unit, route, anatomical location, lot # and expiration date were not reported). On an unknown date in  December 2018, the patient was vaccinated with second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, dose, unit, route, anatomical location, lot # and expiration date were not reported). It was reported that the patient missed the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) that was suppose to occur six months after the initial dose (onset date: Approximately April 2019) (product dose omission). No adverse reaction was reported. The outcome of product dose omission was unknown. No product quality complaint (PQC) was involved.  This is one of the two reports received from the same reporter.
kin rash almost like a chickenpox breakout; experiencing an itching rash in the tronqueal area /  along the extremities, on arms and legs; This case was reported by a pharmacist via call center representative and described the occurrence of varicella-like rash in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number ZR979, expiry date 28th March 2022) for prophylaxis.   On 1st September 2020, the patient received the 1st dose of Shingrix (intramuscular). On 2nd September 2020, 1 days after receiving Shingrix, the patient experienced itchy rash. On 3rd September 2020, the patient experienced varicella-like rash. On an unknown date, the outcome of the varicella-like rash and itchy rash were unknown.   It was unknown if the reporter considered the varicella-like rash and itchy rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. On the following day the patient started experiencing an itching rash in the tronqueal area. On the 2nd day post 1st dose, the rash continued along the extremities, on arms and legs, the skin rash almost like a chickenpox breakout.  The injection had been administered by the intramuscular route on the left deltoid muscle. The reporter did not consent to follow up.
Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in an unspecified numbers of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patients received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patients experienced shingles (Verbatim: Shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by the consumer via interactive digital media. The patient had stated that everyone he/she knew who got the shingles vaccine, got shingles in a week. Follow-up would not possible, as no contact, details were available. This case was 1 of 4 case reported by the same reporter for different patient.; Sender's Comments:  US-GSK-US2023AMR067389:same reporter/other patient US-GSK-US2023AMR025323:same reporter/other patient US-GLAXOSMITHKLINE-US2023AMR025312:same reporter/other patient
Severe headache, nausea, extreme fatigue, body aches.  Developed a temperature of 100.4 on Monday, 1/14/21 at 2:40ish pm
Four days after receiving her vaccine, pt. began experiencing a progression of symptoms.  Starting with Nausea, then vomiting and constipation, extreme pressure in her chest, pain in her abdomen and difficulty swallowing / eating causing significant weight loss (123 lbs to 108 lbs).  She has no or intermittent sensation to urinate and has had multiple catheters and is currently on a Foley catheter due to retetion.  She has Gastroparesis and has not had a bowel movement since this all started.  She began to experience Edema at the end of June and is currently experiencing tingling in her arms and legs since mid July.
A report has been received from a Health Professional concerning a 17 year old, male subject, who had been receiving nasal FLUMIST Quadrivalent.  FLUMIST Quadrivalent started on 12-DEC-2014. The patient accidentally received expired FLUMIST Quadrivalent which started on 12-DEC-2014. The outcome of the event of two patients accidentally received expired FLUMIST Quadrivalent is unknown. The report was considered to be non-serious.
sinus infection; This spontaneous case was reported by a nurse and describes the occurrence of SINUSITIS (sinus infection) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (sinus infection). At the time of the report, SINUSITIS (sinus infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drug details was reported.
Fever, Headache, Joint pains, muscle aches, stomach cramps, Diarrhea, Fatigue all started 7 hours after receiving my booster and all symptoms went away abruptly at 26 hours after my injection. Worse symptoms than previous injections but shorter duration
pt recvd vax & p/mom reached home phoned clinic stating pt crying uncontrollably & shaking;instructed mom to contact MD
Within minutes of receiving her COVID 19 vaccine she developed swelling in her throat, itching, and sinus pressure. No light-headedness and no shortness of breath. Went home, itching got worse that afternoon and then sub-sided. the following way she felt headaches, fatigue, myalgias and developed redness, warmth, and swelling at her right deltoid (injection site). Associated with pain at the injection site. Seen in clinic 3 days after injection, redness and warmth still present. Placed on antibiotics in case this represented cellulitis but patient counseled it was likely a strong immune response to the vaccine.
Muscle weekness 1 hr. after injection. Next day went to ER. Temp: 103. c/o diarrhea,vomited x 1. Stated arm was red and deep purple from shoulder to elbow. Next day she went to PMD. Temp 102. Stated ER or PMD did not look at arm. They told her if it was a reaction that there was nothing they could do. Was given tylenol in ER.  Knot today the size of a jawbreaker. Patient called us 2 weeks after this occurred.
the patient received a monovalent vaccine as a booster not BiValent. However patient told Doctor and her MA that this was her first COVID shot.
5hr p/vax pt devel hypotensive, shock-like state;last approx 10min, then recovered completely;t100.4;
vomiting, diarrhea, pruritus (had questionable hx of yeast allergy ? w/no dietary restrictions);